Drugs / Choriomon5000 IU
Choriomon5000 IU
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05397795 | Jun → Dec 2022 | infertility disorder | Alexandria University | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Choriomon5000 IU | “10000 IU of hCG (Choriomon5000 IU; IBSA) given intramuscularly” NCT05397795 ↗ |
| Known as | hCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05397795 ↗ |
| Known as | human chorionic gonadotrophin | “The aim of the study is to compare the oocyte yield , oocyte quality and the ongoing pregnancy rate between dual trigger treatment (combination of gonadotrophin-releasing...” NCT05397795 ↗ |
| Known as | human chorionic gonadotropin | “Traditionally, human chorionic gonadotropin (hCG) has been the trigger of choice for oocyte maturation due to its molecular and biological similarity with LH.” NCT05397795 ↗ |
| Route | Intramuscular | “10000 IU of hCG (Choriomon5000 IU; IBSA) given intramuscularly” NCT05397795 ↗ |